Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Preparative HPLC. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114349824A reveals a dual-HPLC purification strategy for Linaclotide achieving over 99% purity. Discover cost-effective supply chain solutions for high-quality peptide intermediates.
Novel HPLC method refines Pitressin acetylation impurity with high purity. Reduces organic waste and enables scalable production for pharmaceutical quality control.
Patent CN105037452B reveals high-purity purification. Reduces cost and ensures supply continuity for pharmaceutical intermediates.
Patent CN105017401B reveals a novel HPLC method using 300A pore fillers to maximize yield and minimize polymeric impurities in ziconotide manufacturing.
Advanced purification method for Teriparatide acetate ensuring USP 40 compliance, high purity, and controlled ion content for reliable pharmaceutical supply chains.
Patent CN114315973A reveals a novel two-step HPLC purification for procatide, ensuring high purity and yield for reliable pharmaceutical intermediates supply chains.
Optimized synthesis of DOTA-EB-PSMA precursor reduces HPLC steps ensuring high purity and scalable supply for prostate cancer radioligand therapy manufacturing.
Advanced HPLC purification method for vasopressin acetylated impurities using super water-resistant fillers. Reduces organic waste and ensures high purity for pharmaceutical quality control.
Novel dual-HPLC method achieves >99.8% purity for Cetrorelix. Eliminates precipitation risks, ensuring scalable production and cost reduction for pharmaceutical manufacturers.